Alternative investment manager Pamplona Capital Management has completed its acquisition of PAREXEL International Corporation, a global biopharmaceutical services company. Pamplona acquired all outstanding shares of PAREXEL for $88.10 per share in cash.

The transaction was approved overwhelmingly by stockholders on September 15, with more than 98% of votes ca